IndraLab

Statements

USP1 activates Precursor B-Cell Lymphoblastic Leukemia-Lymphoma. 1 / 1

| 1

eidos

"Taken together , these results demonstrate that USP1 promote B-ALL progression at least partially via the ID1 / AKT signaling pathway , and USP1 inhibitors might be promising therapeutic application for B-ALL ."

33390793

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP1 activates Precursor B-Cell Lymphoblastic Leukemia-Lymphoma. 1 / 1

INDRA sources:

Databases

Reading